A Bacteria-Responsive Porphyrin for Adaptable Photodynamic/Photothermal Therapy

Angew Chem Int Ed Engl. 2022 Jun 7;61(23):e202200799. doi: 10.1002/anie.202200799. Epub 2022 Apr 7.

Abstract

We report a cationic porphyrin 5,10,15,20-tetrakis-(4-N-methylpyridyl)-porphyrin (TMPyP) that can respond to specific bacteria, followed by adaptable photodynamic/photothermal therapy processes. TMPyP could be reduced to phlorin by facultative anaerobes with a strong reducing ability such as E. coli and S. typhimurium in hypoxic environments, possessing strong NIR absorption and remarkable photothermal conversion capacity, thus demonstrating excellent antimicrobial activity (>99 %) by photothermal therapy. While in an aerobic environment with aerobic bacteria, TMPyP functioned as a typical photosensitizer that killed bacteria effectively (>99.9 %) by photodynamic therapy. By forming a host-guest complex with cucurbit[7]uril, the biocompatibility of TMPyP significantly improved. This kind of bacteria-responsive porphyrin shows specificity and adaptivity in antimicrobial treatment and holds potential in non-invasive treatments of bacterial infections.

Keywords: Antibacterial; Photochemistry; Photodynamic Therapy; Photothermal Therapy; Supramolecular Chemistry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents*
  • Bacteria
  • Escherichia coli
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Photothermal Therapy
  • Porphyrins* / pharmacology

Substances

  • Anti-Infective Agents
  • Photosensitizing Agents
  • Porphyrins